Fundies. English
Tiziana Life Sciences plc
EDGAR356 filing records in this dataset, filed from 2018-07-26 to 2026-09-30. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 4.01 million USD Source
Exact value
4010000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- Not available
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-09-30.
Financial data available through: 2025-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 10 of 11 periods available· newest 2025-12-31
- net income: No compatible figures in this window
- Operating cash flow: 9 of 11 periods available· newest 2025-12-31
- Capital expenditure: 7 of 11 periods available· newest 2025-12-31
- Total assets: 9 of 11 periods available· newest 2025-12-31
- Total liabilities: 9 of 11 periods available· newest 2025-12-31
- Current assets: 9 of 11 periods available· newest 2025-12-31
- Current liabilities: 9 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 10 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Operating cash flow
−USD 11.32 millionPrior period
−USD 1.53 million
–
Current period
−USD 12.85 million
–
Exact inputs and evidence
-12847000 − -1526000 = -11321000 USD
-1526000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-12847000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+10.5%Prior period
USD 19,000
–
Current period
USD 21,000
–
Exact inputs and evidence
21000 − 19000 = 2000 USD
19000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source21000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Net income.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | Unavailable Not reported for this period. | Unavailable Not reported for this period. | USD 48,000 Exact valueExact value: 48000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period. |
| 2017 2017-01-01 – 2017-12-31 | Unavailable Not reported for this period. | −USD 7.53 million Exact valueExact value: -7533000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1,000 Exact valueExact value: 1000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.53 million Calculation and evidence-7533000 − 1000 USD Exact free cash flow: -7534000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | Unavailable Not reported for this period. | −USD 4.6 million Exact valueExact value: -4602000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | Unavailable Not reported for this period. | −USD 6.8 million Exact valueExact value: -6796000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4,000 Exact valueExact value: 4000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6.8 million Calculation and evidence-6796000 − 4000 USD Exact free cash flow: -6800000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | Unavailable Not reported for this period. | −USD 11.34 million Exact valueExact value: -11335000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3,000 Exact valueExact value: 3000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 11.34 million Calculation and evidence-11335000 − 3000 USD Exact free cash flow: -11338000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | Unavailable Not reported for this period. | −USD 21.76 million Exact valueExact value: -21762000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 22,000 Exact valueExact value: 22000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 21.78 million Calculation and evidence-21762000 − 22000 USD Exact free cash flow: -21784000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | Unavailable Not reported for this period. | −USD 19.62 million Exact valueExact value: -19615000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | Unavailable Not reported for this period. | −USD 15.7 million Exact valueExact value: -15698000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | Unavailable Not reported for this period. | −USD 1.53 million Exact valueExact value: -1526000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 19,000 Exact valueExact value: 19000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.55 million Calculation and evidence-1526000 − 19000 USD Exact free cash flow: -1545000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | Unavailable Not reported for this period. | −USD 12.85 million Exact valueExact value: -12847000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 21,000 Exact valueExact value: 21000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.87 million Calculation and evidence-12847000 − 21000 USD Exact free cash flow: -12868000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
356 filings · 451 latest values · 451 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001723069, 1723069, TLSA, edgar:1723069
Also known as Tiziana Life Sciences Ltd, Tiziana Life Sciences Ltd, Tiziana Life Sciences plc